Compare VIR & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ARCO |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | Uruguay |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2019 | 2011 |
| Metric | VIR | ARCO |
|---|---|---|
| Price | $10.92 | $7.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $19.43 | $8.60 |
| AVG Volume (30 Days) | ★ 1.9M | 873.6K |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | $270.22 | $12.56 |
| Revenue Next Year | N/A | $3.48 |
| P/E Ratio | ★ N/A | $7.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.75 | $6.54 |
| 52 Week High | $11.94 | $9.75 |
| Indicator | VIR | ARCO |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 37.43 |
| Support Level | $8.43 | $7.44 |
| Resistance Level | $10.67 | $8.20 |
| Average True Range (ATR) | 0.53 | 0.20 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 16.19 | 3.91 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Its menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others. It generates maximum revenue from Brazil.